Archives
-
Indometacin Sodium: Designing Better Assays
2026-09-19
Indometacin Sodium can do more than suppress prostaglandin production: it can help researchers build phenotype-first inflammation, pain, and neurorepair assays. This article translates lessons from a stroke-mimic case report into practical controls for interpreting C6491 experiments.
-
CX-5461: RNA Polymerase I Inhibitor Workflow
2026-09-18
CX-5461 enables mechanism-led cancer research by connecting Pol I-driven rRNA suppression with DNA damage, mitotic catastrophe, autophagy, and senescence. This practical guide covers dosing, orthogonal readouts, cisplatin combination studies, formulation handling, and troubleshooting for reproducible solid-tumor experiments.
-
Indometacin Sodium: From COX Biology to Translation
2026-09-18
Indometacin Sodium Trihydrate offers translational researchers a practical way to connect prostaglandin synthesis inhibition with inflammation, pain signaling, oligodendrocyte differentiation, and Wnt/β-catenin biology. This thought-leadership guide shows how to position the compound in rigorous inflammation assays while separating mechanistic hypotheses from clinically validated evidence.
-
DMG-PEG2000-NH2: An Assay-First Design Guide
2026-09-17
DMG-PEG2000-NH2 is an NH2-PEG derivative that connects lipid assembly with selective bioconjugation. This assay-first guide explains how to evaluate its amide chemistry, lipid nanoparticle performance, and relevance to antimycobacterial delivery without confusing formulation effects with cargo biology.
-
DMG-PEG2000-NH2: An Assay-First Guide
2026-09-17
DMG-PEG2000-NH2 is an NH2-PEG derivative that connects lipid assemblies with covalent biomolecule coupling. This assay-first guide explains how to select, formulate, and validate it while using a tuberculosis medicinal-chemistry study to sharpen experimental decision-making.
-
LY-411575: A Practical Gamma-Secretase Inhibitor Workflow
2026-09-16
LY-411575 enables parallel investigation of amyloid beta processing and Notch-dependent tumor biology, with workflows tailored to biochemical, cellular, and immune-microenvironment assays. This guide combines product-aware handling, pathway-specific readouts, and troubleshooting strategies for Alzheimer’s disease research and cancer research.
-
Reactive Oxygen Species Assay Kit (DHE) Guide
2026-09-16
The Reactive Oxygen Species Assay Kit uses a dihydroethidium (DHE) probe for comparative intracellular superoxide measurement in living cells. Its strongest use is controlled oxidative stress assay work, provided researchers distinguish DHE-derived fluorescence from absolute or species-specific ROS quantification.
-
DMG-PEG2000-NH2 for LNP Conjugation Workflows
2026-09-15
DMG-PEG2000-NH2 combines a lipid-compatible DMG segment, PEG2000 spacer, and reactive primary amine for controlled biomolecule attachment. This article presents practical coupling, purification, LNP formulation, siRNA encapsulation, and troubleshooting workflows while separating product-enabled applications from evidence generated in a distinct sulfonamide study.
-
Rimonabant (SR141716) Workflow for CB1 Research
2026-09-15
Build cleaner CB1 experiments with Rimonabant (SR141716), from appetite and obesity research to inflammation and neurobiology assays. A practical workflow separates CB1-dependent effects from A2A-receptor mechanisms highlighted in recent terpene pain research, while addressing formulation, cytotoxicity, and behavioral confounds.
-
Axitinib (AG 013736) Cancer Assay Workflows
2026-09-14
Build more informative angiogenesis and cancer biology experiments with Axitinib (AG 013736), from VEGF-stimulated endothelial assays to paired viability and cell-death measurements. This workflow emphasizes dosing discipline, signaling confirmation, and practical troubleshooting so apparent drug response is not confused with simple growth arrest.
-
TRIB3, Ferroptosis, and Sunitinib Sensitivity in ccRCC
2026-09-14
The reference study identifies TRIB3 as a potential regulator of sunitinib resistance in clear cell renal cell carcinoma, linking TRIB3 depletion to ferroptosis through the SLC7A11/GPX4 antioxidant pathway. Its combination of bioinformatics, siRNA perturbation, drug-response testing, and protein analysis provides a useful framework for mechanistic studies of targeted-therapy resistance.
-
LY-411575 Workflow for Gamma-Secretase Research
2026-09-13
Build cleaner APP and Notch experiments with LY-411575, a sub-nanomolar gamma-secretase inhibitor suited to parallel molecular and functional readouts. This guide combines pathway-specific controls, practical dosing workflows, and troubleshooting strategies for Alzheimer's disease research and cancer research.
-
GSK-923295: A Mechanistic Guide to CENP-E
2026-09-12
GSK-923295 is a potent CENP-E inhibitor for dissecting mitotic kinesin function, chromosome alignment, and tumor-cell vulnerability. This guide adds a practical assay framework for distinguishing motor inhibition from centromere-architecture defects revealed by acute CTCF degradation.
-
Arachidonic Acid: From Lipid Signal to Immune Strategy
2026-09-11
Arachidonic Acid is more than a membrane lipid or inflammation model. Its position at the intersection of eicosanoid biosynthesis, immune-cell signaling, and vaccine response creates a strategic opportunity for translational researchers—provided substrate handling, pathway attribution, and evidence maturity are treated as core design variables.
-
Sulfaphenazole-Derived Sulfonamides Against TB
2026-09-11
Chen and colleagues optimized sulfaphenazole-derived sulfonamides to retain antimycobacterial activity while reducing CYP2C9 inhibition, a liability associated with potential drug–drug interactions. Compound 10d emerged as a useful lead with a reported MIC of 5.69 μg/mL and CYP2C9 IC50 greater than 10 μM, although the evidence remains primarily in vitro.